As regulators lower evidentiary requirements for approval to speed development/review of new drugs for unmet medical needs, payers are demanding more data to justify price premiums. How can companies can navigate these complexities?

Emerging Pharma Leaders

Compliance Top of Mind

There is never a lack of legal or regulatory issues to keep track of—and worry about—in the life sciences industry. The articles from Pharmaceutical Executive provide a look at the latest in compliance for marketing, labeling, and export control, as well as offer tips to stay compliant in the coming years.